SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS RANDOMIZED INTO A TRIAL OF IFN-ALPHA VERSUS CHEMOTHERAPY - NO SIGNIFICANT ADVERSE EFFECT OF PROLONGED IFN-ALPHA ADMINISTRATION
P. Shepherd et al., SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS RANDOMIZED INTO A TRIAL OF IFN-ALPHA VERSUS CHEMOTHERAPY - NO SIGNIFICANT ADVERSE EFFECT OF PROLONGED IFN-ALPHA ADMINISTRATION, Blood, 86(10), 1995, pp. 363-363